Patent | Date |
---|
Anti-ror1 / Anti-cd3 Bispecific Binding Molecules App 20220227866 - Watkins; Jeffry D. ;   et al. | 2022-07-21 |
Cancer Treatment With Ror1 Antibody Immunoconjugates App 20220152214 - Miller; Langdon ;   et al. | 2022-05-19 |
Ror1 Antibody Immunoconjugates App 20220133901 - Lannutti; Brian ;   et al. | 2022-05-05 |
Uses of indolinone compounds Grant 11,285,132 - Lannutti , et al. March 29, 2 | 2022-03-29 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor App 20220088013 - Hamdy; Ahmed ;   et al. | 2022-03-24 |
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment App 20210346382 - Hamdy; Ahmed ;   et al. | 2021-11-11 |
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor Grant 11,166,951 - Hamdy , et al. November 9, 2 | 2021-11-09 |
Therapeutic combinations of a MEK inhibitor and a BTK inhibitor Grant 11,154,554 - Rothbaum , et al. October 26, 2 | 2021-10-26 |
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate App 20210322408 - Lannutti; Brian ;   et al. | 2021-10-21 |
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Grant 11,090,302 - Hamdy , et al. August 17, 2 | 2021-08-17 |
Uses Of Indolinone Compounds App 20200253927 - Kind Code | 2020-08-13 |
Uses of indolinone compounds Grant 10,646,470 - Lannutti , et al. | 2020-05-12 |
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor App 20200069668 - Lannutti; Brian ;   et al. | 2020-03-05 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor App 20200069796 - Hamdy; Ahmed ;   et al. | 2020-03-05 |
ROR1 Antibody Immunoconjugates App 20200030454 - Lannutti; Brian ;   et al. | 2020-01-30 |
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment App 20190381044 - Hamdy; Ahmed ;   et al. | 2019-12-19 |
Therapeutic Combinations of an Antifolate and a BTK Inhibitor App 20190374543 - Kaptein; Allard ;   et al. | 2019-12-12 |
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor App 20190374539 - Rothbaum; Wayne ;   et al. | 2019-12-12 |
Therapeutic Combination of a PI3K Inhibitor and a BTK Inhibitor App 20190358235 - HAMDY; Ahmed ;   et al. | 2019-11-28 |
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesi App 20190314369 - Lannutti; Brian ;   et al. | 2019-10-17 |
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor App 20190290644 - Hamdy; Ahmed ;   et al. | 2019-09-26 |
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor App 20190209591 - Lannutti; Brian ;   et al. | 2019-07-11 |
ROR1 antibody immunoconjugates Grant 10,335,496 - Lannutti , et al. | 2019-07-02 |
Therapeutic combination of PI3K inhibitor and a BTK inhibitor Grant 10,328,080 - Hamdy , et al. | 2019-06-25 |
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Grant 10,272,083 - Hamdy , et al. | 2019-04-30 |
Therapies For Hematologic Malignancies App 20190083498 - GALLATIN; W. Michael ;   et al. | 2019-03-21 |
Therapeutic Combinations of a BTK Inhibitor and a GITR Binding Molecule, a 4-1BB Agonist, or an OX40 Agonist App 20190022092 - Rothbaum; Wayne ;   et al. | 2019-01-24 |
Uses Of Indolinone Compounds App 20190022062 - Lannutti; Brian ;   et al. | 2019-01-24 |
Therapeutic Combinations of an Antifolate and a BTK Inhibitor App 20190008869 - Kaptein; Allard ;   et al. | 2019-01-10 |
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor App 20190008859 - Rothbaum; Wayne ;   et al. | 2019-01-10 |
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment App 20180369244 - Hamdy; Ahmed ;   et al. | 2018-12-27 |
ROR1 Antibody Immunoconjugates App 20180369406 - Lannutti; Brian ;   et al. | 2018-12-27 |
Uses of indolinone compounds Grant 10,159,660 - Lannutti , et al. Dec | 2018-12-25 |
Therapies for hematologic malignancies Grant 10,154,998 - Gallatin , et al. Dec | 2018-12-18 |
Therapeutic Combinations of a CD19 Inhibitor and a BTK Inhibitor App 20180317602 - Rothbaum; Wayne ;   et al. | 2018-11-08 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor App 20180250298 - Hamdy; Ahmed ;   et al. | 2018-09-06 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK4/6 Inhibitor App 20180250400 - Hamdy; Ahmed ;   et al. | 2018-09-06 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor App 20180207154 - Hamdy; Ahmed ;   et al. | 2018-07-26 |
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor Grant 9,949,971 - Hamdy , et al. April 24, 2 | 2018-04-24 |
Uses Of Indolinone Compounds App 20180028495 - Lannutti; Brian ;   et al. | 2018-02-01 |
Therapeutic Combination of PI3K Inhibitor and a BTK Inhibitor App 20170266191 - Hamdy; Ahmed ;   et al. | 2017-09-21 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor App 20170239351 - Hamdy; Ahmed ;   et al. | 2017-08-24 |
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment App 20170231995 - Hamdy; Ahmed ;   et al. | 2017-08-17 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor App 20170231986 - Hamdy; Ahmed ;   et al. | 2017-08-17 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK 4/6 Inhibitor App 20170224819 - Hamdy; Ahmed ;   et al. | 2017-08-10 |
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate App 20170143712 - Lannutti; Brian ;   et al. | 2017-05-25 |
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor App 20170136014 - Hamdy; Ahmed ;   et al. | 2017-05-18 |
Combination Therapies For Hematologic Malignancies App 20170119771 - GALLATIN; W. Michael ;   et al. | 2017-05-04 |
Therapies For Hematologic Malignancies App 20170112841 - GALLATIN; W. Michael ;   et al. | 2017-04-27 |
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor App 20170095471 - Ahmed; Hamdy ;   et al. | 2017-04-06 |
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor App 20170071962 - Lannutti; Brian ;   et al. | 2017-03-16 |
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor App 20170035881 - Lannutti; Brian ;   et al. | 2017-02-09 |
Therapies for hematologic malignancies Grant 9,492,449 - Gallatin , et al. November 15, 2 | 2016-11-15 |
Therapies For Treating Myeloproliferative Disorders App 20160279135 - Lannutti; Brian ;   et al. | 2016-09-29 |
Combination Therapies For Hematologic Malignancies App 20150196564 - GALLATIN; W. Michael ;   et al. | 2015-07-16 |
Therapies For Treating Myeloproliferative Disorders App 20150148345 - Lannutti; Brian ;   et al. | 2015-05-28 |
Methods Of Treatment For Solid Tumors App 20130344138 - PURI; Kamal D. ;   et al. | 2013-12-26 |
Methods of treatment for solid tumors Grant 8,546,409 - Puri , et al. October 1, 2 | 2013-10-01 |
Compositions And Methods Of Treating A Proliferative Disease With A Quinazolinone Derivative App 20130143902 - Evarts; Jerry B. ;   et al. | 2013-06-06 |
Therapies For Hematologic Malignancies App 20130071323 - Gallatin; W. Michael ;   et al. | 2013-03-21 |
Combination Therapies For Hematologic Malignancies App 20130064812 - GALLATIN; W. Michael ;   et al. | 2013-03-14 |
Methods Of Treating Hematological Disorders With Quinazolinone Compounds In Selected Subjects App 20110306622 - LANNUTTI; Brian ;   et al. | 2011-12-15 |
Methods Of Treatment For Solid Tumors App 20110044942 - PURI; Kamal D. ;   et al. | 2011-02-24 |